No Surgery, No Cutting, No Radiation
Focal One (edap-tms.com) scores 81 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Technology brands, in the 82nd percentile of 22071 Healthcare brands.
Focal One is a medical device developed by EDAP TMS, headquartered in Vaulx-en-Velin, France, and founded in 1979. It uses high intensity focused ultrasound (HIFU) robotic technology to treat prostate conditions, including localized prostate cancer, with submillimetric precision. The device is designed to ablate targeted prostate tissue while sparing surrounding healthy tissue, offering a non-invasive alternative to surgery or radiation. It is marketed to urologists, oncologists, and healthcare providers seeking minimally invasive treatment options for patients with prostate disease.
| Brand Name | Focal One |
|---|---|
| Domain | edap-tms.com |
| Industry | Healthcare, Technology |
| Founded | 1979 |
| Headquarters | Vaulx-en-Velin |
| Parent Company / Owner | EDAP TMS |
| Main Competitors | SonaCare Medical (Sonablate), Profound Medical (TULSA-PRO), AngioDynamics (NanoKnife), Insightec (Exablate), Boston Scientific (Rezum, cryotherapy systems) (80/100) |
Ranked #4,181,353 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Focal One offers a non-invasive prostate treatment using high intensity focused ultrasound (HIFU), while sparing healthy surrounding tissue and minimizing side effects." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, YouTube; no detected presence on LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is Focal One?", Claude could identify the brand as of November 2026. Focal One is a robotic HIFU (high-intensity focused ultrasound) device made by EDAP TMS, used to treat localized prostate cancer by precisely ablating tumor tissue while sparing surrounding structures. Best known for Robotic HIFU treatment for localized prostate cancer, offering a non-surgical, image-guided alternative to prostatectomy or radiation.
When asked "Best brands similar to Focal One?", Claude would recommend Focal One as of November 2026. It's one of the leading HIFU platforms for prostate cancer treatment and would naturally come up when discussing focal therapy options in urology.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Focal One offers a robotic HIFU (high intensity focused ultrasound) system used for non-invasive, precise ablation of prostate tissue, intended as an alternative treatment to surgery, cutting, or radiation for prostate cancer and related conditions.
Sources: Focal One official site
Focal One is a medical device manufactured by EDAP TMS, a French company based in Vaulx-en-Velin. It is a robotic system that uses high intensity focused ultrasound (HIFU) to treat prostate conditions, including localized prostate cancer, in a non-invasive manner.
Sources: Focal One official site
Focal One has limited AI-search visibility, scoring 32/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 33, recommendation 51). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Focal One official site
Focal One was founded in 1979. Focal One operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Focal One is headquartered in Vaulx-en-Velin. Focal One operates in the Healthcare category.
Sources: Wikidata
Focal One delivers high intensity focused ultrasound energy through a robotic platform to precisely ablate targeted prostate tissue. It is designed to treat prostate cancer and related conditions without surgical incision, cutting, or radiation, while sparing healthy tissue surrounding the treatment area.
Sources: Focal One official site
Focal One scores 51/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Focal One official site
Focal One is known for its submillimetric precision in delivering HIFU energy to the prostate, enabling focal (targeted) treatment of prostate tissue rather than whole-gland removal, which is intended to reduce side effects commonly associated with surgery or radiation therapy.
Sources: Focal One official site
Focal One can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Focal One official site
Focal One is used by urologists, oncologists, and other healthcare providers who seek minimally invasive treatment options for patients with prostate cancer or related prostate conditions.
Sources: Focal One official site
Focal One scores 32/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Focal One has a weak AI-visibility profile at 32/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (51/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #4,181,353 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Focal One from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Focal One: Eczema Society of Canada (81/100), Eating Disorders Coalition (81/100), The Eden Alternative (81/100), Eden Labs (81/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.